December 6, 2022

Forex Solution

Learn To Trade Forex

Biogenic Alzheimer’s drug approved by FDA

1 min read

The stock has been halted and awaits being reopened

The FDA has approved Biogen’s Alzheimer drug Aducanumab using an accelerated approval pathway.  The FDA does require Biogen to conduct a postapproval clinical trial and said that they can take away the approval upon unfavorable results.  

Source link

Copyright © All rights reserved. | Newsphere by AF themes.